BridgeMD
New treatment option for Stroke
Official title Variable Intensive Early Walking Post-Stroke - 2 (VIEWS-2)
ClinicalTrials.gov ID: NCT05727930
What this study is testing
- What it's testing
- The proposed research will evaluate the individual and combined effects of task-specificity and intensity of rehabilitation interventions on locomotor function, community mobility and quality of life in patients with subacute (1-6 months) post-stroke.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Sub-acute stroke (1-6 months)
- Hemiparesis (Fugl-Meyer \<34) without cerebellar deficits
- Ability to ambulate with or without physical assistance over 10 meters but \< 1.0 m/s and assistive devices and below-knee bracing is allowed.
- Ability to sit \> 30 seconds without upper-extremity support or physical assistance
- Ability to follow 3-step commands
You likely can't join if
- Significant cardiovascular, metabolic, or respiratory disease that limits exercise participation (e.g. previous myocardial infarction \ 210/110 mmHg...
- If during the graded-treadmill exercise evaluation, the participant presents with absolute criteria for termination of exercise testing during...
- Any orthopedic or neurological disorders that limited walking to \<50m prior to stroke onset.
- Cannot receive physical therapy once baseline testing begins
- If patients are prescribed botulinum toxin for their lower extremities will be excluded only if the dosage for any specific muscle is \>50 units in...
See the full eligibility criteria
- Sub-acute stroke (1-6 months)
- Hemiparesis (Fugl-Meyer \<34) without cerebellar deficits
- Ability to ambulate with or without physical assistance over 10 meters but \< 1.0 m/s and assistive devices and below-knee bracing is allowed.
- Ability to sit \> 30 seconds without upper-extremity support or physical assistance
- Ability to follow 3-step commands
- Provision of informed consent and medical clearance from a supervising physician or medical provider to participate
- Must have the ability to consent or have a legal health care power of attorney or legally authorized representative to consent for participation on their behalf
- Significant cardiovascular, metabolic, or respiratory disease that limits exercise participation (e.g. previous myocardial infarction \ 210/110 mmHg, uncontrolled diabetes, end-stage renal disease, severe infectious or...
- If during the graded-treadmill exercise evaluation, the participant presents with absolute criteria for termination of exercise testing during initial testing (e.g. moderate to severe angina, ST elevation \> 1.0mm...
- Any orthopedic or neurological disorders that limited walking to \<50m prior to stroke onset.
- Cannot receive physical therapy once baseline testing begins
- If patients are prescribed botulinum toxin for their lower extremities will be excluded only if the dosage for any specific muscle is \>50 units in leg muscles above the knee. If doses are \> than 50 units in leg...
The study team makes the final eligibility decision.
Where it's taking place
- Indianapolis, Indiana, United States
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Indianapolis, Indiana, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.